Employer record no. 1783
Alexion Pharmaceuticals, Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
268
Certified
257
Denied
1
FY2025 filings
49
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#106 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 17 | 17 | 0 | $119,378 | $100,077 |
| FY2021 | 28 | 25 | 0 | $145,316 | $118,999 |
| FY2022 | 29 | 28 | 0 | $117,626 | $98,937 |
| FY2023 | 52 | 52 | 0 | $119,706 | $97,922 |
| FY2024 | 57 | 52 | 0 | $152,078 | $106,156 |
| FY2025 | 49 | 48 | 0 | $144,306 | $109,730 |
| FY2026 * | 36 | 35 | 1 | $148,884 | $109,382 |
What they file for
- development scientist ii, bioanalytical development$129,5355
- associate director, biostatistics$185,1104
- quantitative pharmacology programmer analyst$125,0004
- senior manager, medical affairs technologies$157,3454
- associate director$153,7003
- associate director, commercial data analytics and reporting$170,8873
- associate scientist ii, ivivp$85,4663
- associate scientist iii$107,0233
Where
- new haven, ct105
- boston, ma102
- cambridge, ma10
- lexington, ma5
- danbury, ct3
- gaithersburg, md3
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Alexion Pharmaceuticals, Inc. and any other employer they watch.
Certification rate 95.9%How these numbers are computed